Page last updated: 2024-11-05

1-methylquinolinium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Methylquinolinium is a cationic heterocyclic compound that serves as a key intermediate in the synthesis of various pharmaceuticals and dyes. It is also known to exhibit significant biological activity, including antibacterial, antifungal, and anticancer properties. Notably, 1-methylquinolinium is a component of the dye methylene blue, widely used in medicine as an antidote for cyanide poisoning and as a diagnostic tool for certain medical conditions. The compound's reactivity and potential medicinal applications have led to extensive research on its synthesis, chemical properties, and biological effects. '

1-methylquinolinium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19849
CHEMBL ID70369
SCHEMBL ID307903
SCHEMBL ID13814519
MeSH IDM0087125

Synonyms (10)

Synonym
1-methyl-quinolinium
CHEMBL70369
1-methylquinolinium
1-methylquinolin-1-ium
AKOS000638010
quinolinium, 1-methyl-
21979-19-1
SCHEMBL307903
SCHEMBL13814519
DTXSID60176391
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID61001The maximal DA release induced by perfusion with 10 mM MPP+ (15 min) 1 day after perfusion with the test compound with basal striatal DA (%of basal x10E-3)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID172324Percentage of basal lactate efflux before starting the drug perfusion (150 min) with average basal level 689+/-103 pmol/min1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID61002The maximum dopamine release induced by perfusion with the test compound with basal striatal DA (%of basal x10E-3)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID172322Percentage of basal lactate efflux before starting the drug perfusion (15 min) with average basal level 689+/-103 pmol/min1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID1445036Inhibition of recombinant human NNMT triple mutant expressed in Escherichia coli BL21/DE3 cells using NCA as substrate assessed as decrease in 1-MN formation in presence of SAM, SAH by HPLC-UV method2017Journal of medicinal chemistry, 06-22, Volume: 60, Issue:12
Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's6 (54.55)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.54 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]